GlassScriptPhysician profile
Alvaro Javier Testa
NPI 1114120334
$5,567.01
in general payments reported to CMS, 2019-2025
16 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $141 · 2021: $499 · 2022: $2,129 · 2023: $913 · 2024: $1,034 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,705.10 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $1,414.85 | 2021-2023 | |
| Tela Bio, INC. | $531.87 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $431.17 | 2019-2022 | |
| Integra Lifesciences Corporation | $422.09 | 2023 | Durasorb Monofilament Mesh |
| Davol INC. | $369.94 | 2019-2024 | Phasix Mesh |
| Sanara Medtech INC. | $332.19 | 2023-2024 | Celleraterx |
| Inspire Medical Systems, INC. | $99.23 | 2023-2025 | Inspire |
| Sientra, INC. | $77.36 | 2020-2021 | |
| Mimedx Group, INC. | $59.51 | 2024 | |
| Acell, INC. | $48.38 | 2019 | |
| Access Pro Medical, LLC | $25.88 | 2025 | Matriderm |
| Ethicon US, LLC | $20.33 | 2023 | Echelon; Endopath |
| Axonics, INC. | $15.03 | 2021 | |
| Acera Surgical, INC. | $14.08 | 2023 | Restrata Wound Matrix |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alvaro Testa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.